Nakano et al. have shown that the serum FGF23 level in CKD stages 1 and 2 in diabetic patients is lower than that in nondiabetic patients due to dysfunction or decreased density of osteocytes and that diabetes mellitus affects vitamin D metabolism[12]. This evidence concerns the gene FGF23 and diabetes mellitus.